26313df6-figure-09 (20 mg 30 Capsule)
Duloxetine Capsule, Delayed Release
Product Images NDC 43547-379
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 43547-379). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
26313df6-figure-10 (30mg 30 Capsules)
This text appears to be a medication label for Duloxetine Delayed-Release Capsules. It provides information on the dosage and storage instructions, including the temperature conditions for storage. The medication is manufactured by Thejan Huahai Pharmaceutical Co. in China and distributed by Soothe Healthcare in the USA. The label also includes a warning to keep the medication out of reach of children.*
26313df6-figure-11 (60 mg 30 Capsule)
Duloxetine Delayed-Release Capsules are medication capsules containing 67.3 mg of duloxetine hydrochloride, equivalent to 60 mg of duloxetine. Users should not use this medication if the bottle seal is missing or broken. The usual dosage is provided in the accompanying information pamphlet. The medication should be stored between 20-25°C (68-77°F) and can be briefly stored between 15-30°C (59-86°F). The medication should be stored in a tightly closed container and out of reach of children. These capsules are manufactured by The Jiangsu Hua Hai Pharmaceutical Co, Ltd., in China, and are distributed by LUPIN in Somerset, NJ 08873, USA.*
Image 01
Image 02
The text is a graph showing the proportion of patients with relapse over time from randomization to relapse. The graph compares two treatments, the placebo and Duloxetine. The x-axis displays time from randomization to relapse (in days), while the y-axis displays the proportion of patients with relapse. There are 6 data points displayed on the graph for each treatment over 300 days.*
Image 03
Image 04
Image 05
Image 06
The text displays a graph representing the percentage of patients improved. The horizontal axis represents the percent improvement in pain from the baseline, and the vertical axis represents the percentage of patients improved. The graph includes four different lines, each representing a different treatment: Duloxetine 120mg once daily, Duloxetine 60mg once daily, Duloxetine 20mg once daily, and Placebo.*
Image 07
This is a chart indicating the percentage of patients improved with Duloxetine 60/120 mg Once daily compared to a placebo, based on the percent improvement in pain from baseline. The percentage of improvement with Duloxetine ranges from 70% to 100%, while the percentage of improvement with the placebo is not provided.*
Image 08
The text shows a graph displaying the percentage of patients who showed improvement after treatment. The graph compares the effectiveness of a placebo with Duloxetine 60 mg once daily in reducing pain, with the x-axis representing the percentage of improvement in pain from baseline, and the y-axis displaying the number of patients.*
Image 09
This is a graph showing the percentage of patients improved in pain from baseline (BOCF) for a placebo and Duloxetine 60/120 mg once daily. The X-axis represents percent improvement in pain and the Y-axis represents the number of patients. The graph suggests that Duloxetine may be more effective in improving pain than a placebo.*
C:\users\ra\desktop\duloxetine-spl\molecular.jpg (Structure)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
